Thomas F. Bumol
- Molecular Biology top 5%
- Oncology top 5%
- Radiology, Nuclear Medicine and Imaging top 2%
- Immunology top 5%
- Physiology top 10%
- Co-authors
- R. ReisfeldAlexei KharitonenkovDavid E. MollerHaoda FuWilliam L. HollandGregory GaichMark A. DeegJenny Y. Chien
- Topics
- Monoclonal and Polyclonal Antibodies Research (17 papers)Glycosylation and Glycoproteins Research (11 papers)HER2/EGFR in Cancer Research (7 papers)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Thomas F. Bumol
42 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Molecular Biology 1.7k
- Oncology 692
- Radiology, Nuclear Medicine and Imaging 603
- Immunology 482
- Physiology 266
Countries citing papers authored by Thomas F. Bumol
This map shows the geographic impact of Thomas F. Bumol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas F. Bumol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas F. Bumol more than expected).
Fields of papers citing papers by Thomas F. Bumol
This network shows the impact of papers produced by Thomas F. Bumol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas F. Bumol. The network helps show where Thomas F. Bumol may publish in the future.
Co-authorship network of co-authors of Thomas F. Bumol
This figure shows the co-authorship network connecting the top 25 collaborators of Thomas F. Bumol. A scholar is included among the top collaborators of Thomas F. Bumol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas F. Bumol. Thomas F. Bumol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 2 | |
| 3 | 70 | |
| 4 | 21 | |
| 5 | 6 | |
| 6 | The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetesbreakdown → | 730 |
| 7 | 146 | |
| 8 | 77 | |
| 9 | 34 | |
| 10 | 34 | |
| 11 | 22 | |
| 12 | 15 | |
| 13 | The human immune response to KS1/4-desacetylvinblastine (LY256787) and KS1/4-desacetylvinblastine hydrazide (LY203728) in single and multiple dose clinical studies. | 37 |
| 14 | 95 | |
| 15 | 56 | |
| 16 | 14 | |
| 17 | 20 | |
| 18 | 23 | |
| 19 | 13 | |
| 20 | 251 |
About Thomas F. Bumol
Thomas F. Bumol is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Immunology and Allergy, having authored 43 papers that have together received 2.8k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (17 papers), Glycosylation and Glycoproteins Research (11 papers) and HER2/EGFR in Cancer Research (7 papers). The work is most often cited by research in Immunology and Allergy (180 citations), Radiology, Nuclear Medicine and Imaging (603 citations) and Oncology (692 citations). Thomas F. Bumol has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include R. Reisfeld, Alexei Kharitonenkov, David E. Moller, Haoda Fu, William L. Holland, Gregory Gaich, Mark A. Deeg, Jenny Y. Chien, Leonard C. Glass and L D Apelgren. Their work appears in journals such as Proceedings of the National Academy of Sciences, JAMA and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.